Lan T, Dun R, Yao D, Wu F, Qian Y, Zhou Y
Front Nutr. 2023; 9:1064507.
PMID: 36687723
PMC: 9845714.
DOI: 10.3389/fnut.2022.1064507.
Athanassiadou V, Plavoukou S, Grapsa E, Detsika M
Antioxidants (Basel). 2022; 11(12).
PMID: 36552662
PMC: 9774641.
DOI: 10.3390/antiox11122454.
Kervella D, Le Bas-Bernardet S, Bruneau S, Blancho G
Front Immunol. 2022; 13:932242.
PMID: 35990687
PMC: 9389360.
DOI: 10.3389/fimmu.2022.932242.
Li T, Chen Q, Dai J, Huang Z, Luo Y, Mou T
Mol Biol Rep. 2022; 49(8):7575-7585.
PMID: 35644004
DOI: 10.1007/s11033-022-07570-3.
Ryter S
Antioxidants (Basel). 2022; 11(3).
PMID: 35326205
PMC: 8944973.
DOI: 10.3390/antiox11030555.
Extract and Its Major Constituents, Methyl Gallate and Quercetin, Potentiate Therapeutic Angiogenesis in Diabetic Hind Limb Ischemia: HPTLC Quantification and LC-MS/MS Metabolic Profiling.
Abdel-Hamed A, Mehanna E, Hazem R, Badr J, Abo-Elmatty D, Abdel-Kader M
Antioxidants (Basel). 2021; 10(11).
PMID: 34829572
PMC: 8614836.
DOI: 10.3390/antiox10111701.
Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease.
Li Y, Ma K, Han Z, Chi M, Sai X, Zhu P
Front Med (Lausanne). 2021; 8:708453.
PMID: 34504854
PMC: 8421649.
DOI: 10.3389/fmed.2021.708453.
HO‑1 knockdown upregulates the expression of VCAM‑1 to induce neutrophil recruitment during renal ischemia‑reperfusion injury.
He Y, Li H, Yao J, Zhong H, Kuang Y, Li X
Int J Mol Med. 2021; 48(4).
PMID: 34368855
PMC: 8416149.
DOI: 10.3892/ijmm.2021.5018.
Chess Not Checkers: Complexities Within the Myeloid Response to the Acute Kidney Injury Syndrome.
Nash W, Okusa M
Front Med (Lausanne). 2021; 8:676688.
PMID: 34124107
PMC: 8187556.
DOI: 10.3389/fmed.2021.676688.
Significance of Heme and Heme Degradation in the Pathogenesis of Acute Lung and Inflammatory Disorders.
Ryter S
Int J Mol Sci. 2021; 22(11).
PMID: 34073678
PMC: 8197128.
DOI: 10.3390/ijms22115509.
Noise-Induced Vascular Dysfunction, Oxidative Stress, and Inflammation Are Improved by Pharmacological Modulation of the NRF2/HO-1 Axis.
Bayo Jimenez M, Frenis K, Kroller-Schon S, Kuntic M, Stamm P, Kvandova M
Antioxidants (Basel). 2021; 10(4).
PMID: 33921821
PMC: 8073373.
DOI: 10.3390/antiox10040625.
Deciphering the Role of Heme Oxygenase-1 (HO-1) Expressing Macrophages in Renal Ischemia-Reperfusion Injury.
Rossi M, Korpak K, Doerfler A, Boudjeltia K
Biomedicines. 2021; 9(3).
PMID: 33809696
PMC: 8002311.
DOI: 10.3390/biomedicines9030306.
Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases.
Grunenwald A, Roumenina L, Frimat M
Int J Mol Sci. 2021; 22(4).
PMID: 33670516
PMC: 7923026.
DOI: 10.3390/ijms22042009.
Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury.
Detsika M, Lianos E
Antioxidants (Basel). 2021; 10(1).
PMID: 33418934
PMC: 7825075.
DOI: 10.3390/antiox10010060.
Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
Rossi M, Piagnerelli M, Van Meerhaeghe A, Boudjeltia K
Med Hypotheses. 2020; 144:110242.
PMID: 33254548
PMC: 7467863.
DOI: 10.1016/j.mehy.2020.110242.
New insights into the role of heme oxygenase-1 in acute kidney injury.
Nath M, Agarwal A
Kidney Res Clin Pract. 2020; 39(4):387-401.
PMID: 33184238
PMC: 7770992.
DOI: 10.23876/j.krcp.20.091.
Heme Oxygenase-1 in liver transplant ischemia-reperfusion injury: From bench-to-bedside.
Hirao H, Dery K, Kageyama S, Nakamura K, Kupiec-Weglinski J
Free Radic Biol Med. 2020; 157:75-82.
PMID: 32084514
PMC: 7434658.
DOI: 10.1016/j.freeradbiomed.2020.02.012.
Molecular strategies used by hibernators: Potential therapeutic directions for ischemia reperfusion injury and preservation of human donor organs.
Soo E, Welch A, Marsh C, McKay D
Transplant Rev (Orlando). 2019; 34(1):100512.
PMID: 31648853
PMC: 7141767.
DOI: 10.1016/j.trre.2019.100512.
The HO-1-expressing bone mesenchymal stem cells protects intestine from ischemia and reperfusion injury.
Yan X, Cheng X, He X, Zheng W, Xiao-Fang Y, Hu C
BMC Gastroenterol. 2019; 19(1):124.
PMID: 31299915
PMC: 6626374.
DOI: 10.1186/s12876-019-1042-9.
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system.
Maruyama K, Nakagawa N, Aonuma T, Saito Y, Hayasaka T, Kano K
Sci Rep. 2019; 9(1):7823.
PMID: 31127150
PMC: 6534557.
DOI: 10.1038/s41598-019-44241-z.